Anti-CTLA-4/CD152 Antibody (Ipilimumab)
Catalog No.
F1221
Anti-CTLA-4/CD152 Antibody (Ipilimumab)
Featured Products
Ipilimumab is a fully human monoclonal IgG1κ antibody that blocks the inhibitory receptor cytotoxic T lymphocyte antigen 4 (CTLA-4) on T cells. Ipilimumab is being studied in unresectable or metastatic melanoma (MM).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet
145.38 kDa
Dry ice
477202-00-9
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Yervoy, MDX-010, MDX101
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P16410
Human, Cynomolgus
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Human CTLA-4 & Human PD-1 CHO-K cells were stained with Anti-CTLA-4 / CD152 Reference Antibody (ipilimumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS
CTLA-4 / CD152
Please avoid freeze-thaw cycles.